• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Model Number CDS0601-NTR
Device Problem Incomplete Coaptation (2507)
Patient Problems Dyspnea (1816); Mitral Regurgitation (1964); Tissue Damage (2104); Atrial Perforation (2511)
Event Date 08/04/2020
Event Type  Injury  
Manufacturer Narrative
The clip remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report the single leaflet device attachment, recurrent mitral regurgitation, and ruptured chordae treated surgically.It was reported that this was a mitraclip procedure to treat grade 4 degenerative mitral regurgitation (mr).On (b)(6) 2020 one mitraclip was implanted reducing mr grade to 1.There were no adverse patient effects and no clinically significant delay in the procedure.On (b)(6) 2020 the patient was seen for a follow-up visit and was noted to have more shortness of breath.The echocardiogram showed a single leaflet device attachment of the mitraclip and two ruptured chordae.The posterior leaflet was no longer in the clip.The mitral valve had characteristic changes of myxomatous degeneration with annular and leaflet enlargement (carpentier classification ii).The patient underwent surgery to treat the mr.There was a large iatrogenic defect in the septum.There was no additional information provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event and a review of the complaint history identified no similar incident reported from this lot.The reported patient effects of tissue damage, dyspnea, mr (mitral regurgitation) and atrial perforation, are listed in the mitraclip instructions for use as known possible complications associated with mitraclip procedures.Based on all available information, the reported slda (single leaflet device attachment) and poor imaging appear to be due to challenging patient anatomy.A cause for the reported tissue damage and atrial perforation could not be determined.The reported dyspnea and recurrent mr were cascading events of the reported tissue damage.There is no indication of a product issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10454853
MDR Text Key204393594
Report Number2024168-2020-07119
Device Sequence Number1
Product Code NKM
UDI-Device Identifier08717648226342
UDI-Public08717648226342
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/08/2020
Device Model NumberCDS0601-NTR
Device Catalogue NumberCDS0601-NTR
Device Lot Number90907U179
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/04/2020
Initial Date FDA Received08/26/2020
Supplement Dates Manufacturer Received09/03/2020
Supplement Dates FDA Received09/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age88 YR
Patient Weight37
-
-